cetylpyridinium chloride anhydrous has been researched along with arginine vasopressin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hijman, R; Laczi, F; Van Ree, JM; Westenberg, HG; Wiegant, VM | 1 |
| Jessop, DS | 1 |
1 review(s) available for cetylpyridinium chloride anhydrous and arginine vasopressin
| Article | Year |
|---|---|
Neuropeptides in the immune system: functional roles in health and disease.
Topics: Animals; Arginine Vasopressin; Corticotropin-Releasing Hormone; Disease; Health; Humans; Immunity; Neuropeptides; Opioid Peptides; Pro-Opiomelanocortin | 2002 |
1 trial(s) available for cetylpyridinium chloride anhydrous and arginine vasopressin
| Article | Year |
|---|---|
Pharmacokinetics of DGAVP in plasma following intranasal and oral administration to healthy subjects.
Topics: Administration, Intranasal; Administration, Oral; Adult; Arginine Vasopressin; Biological Availability; Female; Health; Humans; Male | 1994 |